The regions within the N-terminus critical for human glucagon like peptide-1 receptor (hGLP-1R) cell Surface expression

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Thompson, Aiysha ^a   Kanamarlapudi, Venkateswarlu ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLP1R PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; CELL MEMBRANE; CHEMISTRY; GLYCOSYLATION; HEK293 CELL LINE; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; CELL MEMBRANE; CONSERVED SEQUENCE; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLYCOSYLATION; HEK293 CELLS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEOLYSIS; RECEPTORS, GLUCAGON;

EID: 84938206842     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07410     Document Type: Article

References (35)

1. Thompson, A. & Kanamarlapudi, V. Type 2 Diabetes Mellitus and Glucagon Like Peptide-1 Receptor Signalling. Clin Exp Pharmacol 3, DOI: 2161-1459.1000138, 2013).
2. Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L. & Habener, J. F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 84, 3434-3438 (1987).
3. Holst, J. J. The physiology of glucagon-like peptide 1. Physiol Rev 87, 1409-1439, doi:10.1152/physrev. 00034.2006 (2007).
4. Doyle, M. E. & Egan, J. M. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 113, 546-593, doi:10.1016/j.pharmthera.2006.11.007 (2007).
5. Holz, G. G., Leech, C. A., Heller, R. S., Castonguay, M. & Habener, J. F. cAMPdependent Mobilization of Intracellular Ca Stores by Activation of Ryanodine Receptors in Pancreatic b-Cells. The Journal of biological chemistry 274, 14147-14156 (1999).
6. Gallwitz, B. The evolving place of incretin-based therapies in type 2 diabetes. Pediatr Nephrol 25, 1207-1217, doi:10.1007/s00467-009-1435-z (2010).
7. Kochl, R. et al. The signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane. The Journal of biological chemistry 277, 16131-16138, doi:10.1074/jbc. M111674200 (2002).
8. Hegde, R. S. & Lingappa, V. R. Membrane protein biogenesis: regulated complexity at the endoplasmic reticulum. Cell 91, 575-582 (1997).
9. Ban, T., Kosugi, S. & Kohn, L. D. Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfected with wildtype receptor complementary deoxyribonucleic acid: characterization of their relevance to receptor synthesis, processing, structure, and function. Endocrinology 131, 815-829 (1992).
10. Akamizu, T., Kosugi, S. & Kohn, L. D. Thyrotropin receptor processing and interaction with thyrotropin. BiochemBiophys Res Commun 169, 947-952 (1990).
11. Schulz, K. et al. The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity. The Journal of biological chemistry 285, 32878-32887, doi:10.1074/jbc. M110.129627 (2010).
12. Rutz, C. et al. The corticotropin-releasing factor receptor type 2a contains an Nterminal pseudo signal peptide. The Journal of biological chemistry 281, 24910-24921, doi:10.1074/jbc. M601554200 (2006).
13. Alken, M. et al. The signal peptide of the rat corticotropin-releasing factor receptor 1 promotes receptor expression but is not essential for establishing a functional receptor. Biochem J 390, 455-464, doi:10.1042/BJ20050113 (2005).
14. Huang, Y., Wilkinson, G. F. & Willars, G. B. Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor. Br J Pharmacol 159, 237-251, doi:10.1111/j.1476-5381.2009.00517.x (2010).
15. Hatsuzawa, K., Tagaya, M. & Mizushima, S. The hydrophobic region of signal peptides is a determinant for SRP recognition and protein translocation across the ER membrane. J Biochem 121, 270-277 (1997).
16. Achour, L., Labbe-Jullie, C., Scott, M. G. & Marullo, S. An escort for GPCRs: implications for regulation of receptor density at the cell surface. Trends Pharmacol Sci 29, 528-535, doi:10.1016/j.tips.2008.07.009 (2008).
17. Duvernay, M. T., Filipeanu, C. M. & Wu, G. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal 17, 1457-1465, doi:10.1016/j.cellsig.2005.05.020 (2005).
18. Wallin, E. & Vonheijne, G. Properties of N-Terminal Tails in G-Protein Coupled Receptors - a Statistical Study. Protein Eng 8, 693-698, doi: Doi 10.1093/Protein/8.7.693 (1995).
19. Chen, Q., Miller, L. J. & Dong, M. Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor. Am J Physiol Endocrinol Metab 299, E62-68, doi:10.1152/ajpendo.00067.2010 (2010).
20. Whitaker, G. M., Lynn, F. C., McIntosh, C. H. & Accili, E. A. Regulation of GIP and GLP1 receptor cell surface expression by N-glycosylation and receptor heteromerization. PLoS One 7, e32675, doi:10.1371/journal.pone.0032675 (2012).
21. Van Eyll, B., Goke, B., Wilmen, A. & Goke, R. Exchange of W39 by A within the Nterminal extracellular domain of the GLP-1 receptor results in a loss of receptor function. Peptides 17, 565-570 (1996).
22. Underwood, C. R. et al. Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor. J Biol Chem 285, 723-730, doi: Doi 10.1074/Jbc. M109.033829 (2010).
23. Runge, S., Thogersen, H., Madsen, K., Lau, J. & Rudolph, R. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. The Journal of biological chemistry 283, 11340-11347, doi:10.1074/jbc. M708740200 (2008).
24. Parthier, C. et al. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci U S A 104, 13942-13947, doi:10.1073/pnas.0706404104 (2007).
25. Maley, F., Trimble, R. B., Tarentino, A. L. & Plummer, T. H. Characterization of Glycoproteins and Their Associated Oligosaccharides through the Use of Endoglycosidases. Anal Biochem 180, 195-204, doi: Doi 10.1016/0003-2697 (89) 90115-2 (1989).
26. Couvineau, A., Rouyer-Fessard, C. & Laburthe, M. Presence of aN-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor. Regul Pept 123, 181-185, doi:10.1016/j.regpep. 2004.06.025 (2004).
27. Alken, M. et al. The sequence after the signal peptide of the G protein-coupled endothelin B receptor is required for efficient translocon gating at the endoplasmic reticulum membrane. Mol Pharmacol 75, 801-811, doi:10.1124/mol.108.051581 (2009).
28. Widmann, C., Dolci, W. & Thorens, B. Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. Biochemical Journal 310, 203-214 (1995).
29. Varki, A. et al. Essentials of Glycobiology. 2nd Edition. (Cold Spring Harbour Laboratory Press, 2009).
30. Thompson, A. & Kanamarlapudi, V. Agonist Induced Internalisation of the Glucagon Like Peptide-1 Receptor is Mediated by the Gaq Pathway. Biochemical pharmacology DOI: 10.1016/j.bcp. 2014.10.015, doi: DOI: 10.1016/j.bcp.2014.10.015 (2014).
31. Kanamarlapudi, V. EFA6R requires C-terminal targeting to the plasma membrane to promote cytoskeletal rearrangement through the activation of ARF6. J Biol Chem, doi:10.1074/jbc. M113.534156 (2014).
32. Kanamarlapudi, V., Thompson, A., Kelly, E. & Lopez Bernal, A. ARF6 activated by the LHCG receptor through the cytohesin family of guanine nucleotide exchange factors mediates the receptor internalization and signaling. The Journal of biological chemistry 287, 20443-20455, doi:10.1074/jbc. M112.362087 (2012).
33. Kanamarlapudi, V., Owens, S. E., Lartey, J. & Lopez Bernal, A. ADP-ribosylation factor 6 expression and activation are reduced in myometrium in complicated pregnancies. PLoS One 7, e37954, doi:10.1371/journal.pone.0037954 (2012).
34. Davies, J. C., Bain, S. C. & Kanamarlapudi, V. ADP-ribosylation factor 6 regulates endothelin-1-induced lipolysis in adipocytes. Biochem Pharmacol 90, 406-413, doi:10.1016/j.bcp. 2014.06.012 (2014).
35. Davies, J. C. B., Tamaddon-Jahromi, S., Jannoo, R. & Kanamarlapudi, V. Cytohesin 2/ARF6 regulates preadipocyte migration through the activation of ERK1/2. Biochemical pharmacology 92, 651-660, doi: http://dx.doi.org/10.1016/j. bcp. 2014.09.023 (2014).